-+ 0.00%
-+ 0.00%
-+ 0.00%

Immutep Receives Cash Payment Of €1.36M From French Government Under Tax Incentive Program

Benzinga·10/28/2026 12:02:21
Listen to the news

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a clinical-stage immunotherapy company targeting cancer and autoimmune diseases, today announced that it has received a cash payment of €1.36 million (approximately A$2.16 million) from the French Government under its Crédit d’Impôt Recherche (CIR) research tax incentive program, for eligible R&D activities conducted in calendar year 2025.